New insights highlight clinician support for shared survivorship care and identify key factors for effective implementation.

A new publication by two University of Cincinnati researchers contends that adjusting how researchers approach their statistical analysis has the potential to change the lives of children and ...

At two doses, baxdrostat demonstrated significant reduction in mean seated systolic BP vs. placebo at 12 weeks among patients with uncontrolled or treatment-resistant hypertension, AstraZeneca ...

Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.